| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |